MAX BioPharma Overview

  • Founded
  • 2010
  • Status
  • Private
  • Employees
  • 4
  • Latest Deal Type
  • Series A
  • (Upcoming)
  • Investors
  • 3

MAX BioPharma General Information


Developer of novel small molecule lipids intended to provide treatments for fatal and debilitating disorders. The company develops oxysterols which has the ability to stimulate bone growth and block cancer cell growth as well as inhibit their ability to metastasize, enabling doctors to treat pancreatic cancer, breast cancer and hematologic malignancies.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Drug Discovery
Primary Office
  • 2870 Colorado Avenue
  • Santa Monica, CA 90404
  • United States
+1 (310) 000-0000

MAX BioPharma Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

MAX BioPharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series A) Upcoming Pre-Clinical Trials
4. Grant 27-Aug-2020 000 00000 Completed Pre-Clinical Trials
3. Later Stage VC (Series A) 03-Mar-2020 Cancelled Pre-Clinical Trials
2. Equity Crowdfunding 13-Sep-2018 $2.96K $250K Completed Pre-Clinical Trials
1. Seed Round $250K $250K Completed Startup
To view MAX BioPharma’s complete valuation and funding history, request access »

MAX BioPharma Executive Team (4)

Name Title Board Seat Contact Info
Farhad Parhami Ph.D Co-Founder, President & Chief Executive Officer
Gonzalo Payan Director of Finance and Operations
William Matsui MD Scientific Co-Founder & Scientific Advisor
Michael Jung Ph.D Scientific Co-Founder
To view MAX BioPharma’s complete executive team members history, request access »

MAX BioPharma Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MAX BioPharma Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
California Institute for Regenerative Medicine Government 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
To view MAX BioPharma’s complete investors history, request access »